These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19946241)

  • 21. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F; Kuschyk J; Veltmann C; Ratay D; Schoene N; Streitner I; Brueckmann M; Schumacher B; Borggrefe M; Wolpert C
    Cytokine; 2009 Sep; 47(3):166-72. PubMed ID: 19604708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.
    Bielecka-Dabrowa A; Mikhailidis DP; Rizzo M; von Haehling S; Rysz J; Banach M
    Lipids Health Dis; 2013 Apr; 12():47. PubMed ID: 23566246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
    Chiang CK; Yang SY; Peng YS; Hsu SP; Pai MF; Huang JW; Hung KY; Wu KD
    Am J Nephrol; 2009; 29(5):392-7. PubMed ID: 18974640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
    Tsutamoto T; Sakai H; Ibe K; Yamaji M; Kawahara C; Nakae I; Fujii M; Yamamoto T; Horie M
    Circ J; 2011; 75(9):2160-6. PubMed ID: 21737951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
    Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
    Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM; Beckers P; Vaes J; Martin M; Van Hoof V; De Maeyer C; Possemiers N; Wuyts FL; Vrints CJ
    Eur Heart J; 2004 Oct; 25(20):1797-805. PubMed ID: 15474694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure.
    Cheng X; Ding Y; Xia C; Tang T; Yu X; Xie J; Liao M; Yao R; Chen Y; Wang M; Liao YH
    J Card Fail; 2009 Mar; 15(2):158-62. PubMed ID: 19254676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
    Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure.
    Duan HY; Liu DM; Qian P; Wang SL; Yan LJ; Wu JT; Yang HT; Fan XW; Chu YJ
    Genet Mol Res; 2015 Dec; 14(4):15739-48. PubMed ID: 26634541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.